Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis

Norbert Reiling, Christoph Hölscher, Alexandra Fehrenbach, Svenja Kröger, Carsten J. Kirschning, Sanna Goyert and Stefan Ehlers
J Immunol October 1, 2002, 169 (7) 3480-3484; DOI: https://doi.org/10.4049/jimmunol.169.7.3480
Norbert Reiling
*Division of Molecular Infection Biology, Research Center Borstel, Borstel, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Hölscher
*Division of Molecular Infection Biology, Research Center Borstel, Borstel, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Fehrenbach
*Division of Molecular Infection Biology, Research Center Borstel, Borstel, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Svenja Kröger
*Division of Molecular Infection Biology, Research Center Borstel, Borstel, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carsten J. Kirschning
†Institute of Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanna Goyert
‡Division of Molecular Medicine, Cornell University Medical College, Manhasset, NY 11030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Ehlers
*Division of Molecular Infection Biology, Research Center Borstel, Borstel, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Innate resistance against Mycobacterium tuberculosis is thought to depend critically on engagement of pattern recognition receptors on macrophages. However, the relative contribution of these receptors for containing M. tuberculosis infection has remained unexplored in vivo. To address this issue, we infected mice defective in CD14, TLR2, or TLR4 with M. tuberculosis by aerosol. Following infection with 100 mycobacteria, either mutant strain was as resistant as congenic control mice. Granuloma formation, macrophage activation, and secretion of proinflammatory cytokines in response to low-dose aerosol infection were identical in mutant and control mice. However, high-dose aerosol challenge with 2000 CFU M. tuberculosis revealed TLR2-, but not TLR4-defective mice to be more susceptible than control mice. In conclusion, while TLR2 signaling contributes to innate resistance against M. tuberculosis in borderline situations, its function, and that of CD14 and TLR4, in initiating protective responses against naturally low-dose airborne infection is redundant.

Human tuberculosis caused by Mycobacterium tuberculosis is the most prevalent and deadly bacterial infectious disease world-wide (1). Incomplete understanding of the molecular nature of protective immune responses has hampered the development of more effective vaccines and therapies.

Animal models of low-dose aerosol infection with M. tuberculosis are believed to reflect the typical infection that occurs when humans inhale only a few virulent bacteria aerosolised in the course of an infected individual’s coughing (2, 3). Aerosol infection in mice has been instrumental in defining the prominent features of the cell-mediated immune response now known to be critical in host defense. In particular, CD4+ T cells play an important role in protective granuloma formation by secreting type 1 cytokines (4). Especially IFN-γ and TNF (5) stimulate the antimicrobial activity of infected macrophages (6). Although TNF can activate macrophages in an autocrine loop, the release of IFN-γ by NK and TH1 cells is triggered by IL-12, which is produced by APCs upon infection with mycobacteria (7).

Microbes express pathogen-associated molecular patterns capable of activating APCs following engagement of pattern recognition receptors (PRRs4; Refs. 8 and 9). Specifically, CD14 was reported to be engaged by lipoarabinomannan from M. tuberculosis, although subsequent studies questioned this finding (10, 11). In addition, analysis of transfected chinese hamster ovary fibroblasts suggested that live M. tuberculosis may use both Toll-like receptor (TLR)2 and TLR4 proteins for intracellular signaling (11). On a functional level, the interaction of mycobacterial components with TLRs may be a critical early step of macrophage activation in the course of infection. Thus, stimulation of TLR2 with the M. tuberculosis-derived 19-kDa lipoprotein induced mycobacteriostasis in both human and murine macrophages (12). Because TLR signaling is believed to be essential for the initial production of IL-12p40 and TNF by APCs after infection with M. tuberculosis, it is likely critical also for the induction of a protective cell-mediated immune response (13). In the absence of endogenous IL-12p40 or TNF, mice are severely compromised in terms of type 1 cytokine production, granuloma formation, and protection during mycobacterial infection (14, 15). Therefore, current thinking predicts that deficiencies in PRRs, such as TLR2 or TLR4, will be accompanied by greatly diminished innate immune responses resulting in early exacerbation of M. tuberculosis infection (16, 17, 18).

However, the role of TLR-mediated pathogen recognition for initiating the immune response against M. tuberculosis has thus far remained unexplored in vivo. To address this issue, we analyzed the course of aerosol M. tuberculosis infection in mice deficient in CD14, TLR2, or TLR4.

Materials and Methods

Mice and macrophages

TLR2- (TLR2−/−; 19) and CD14-deficient (CD14−/−) mice (20) were at least sixth generation backcrosses onto a C57BL/6 or BALB/c background, respectively. TLR4-defective C3H/HeJ (21) mice and the following congenic control mice were purchased from Charles River Breeding Laboratories (Sulzfeld, Germany): C57BL/6 (TLR2+/+), BALB/c (CD14+/+), and C3HHeN (TLR4-competent). Bone marrow-derived macrophages were generated as previously described (22).

Bacteria and infection

M. tuberculosis (H37Rv) was grown and prepared for all experiments as described (14). For in vitro experiments, 0.5 × 106 macrophages were infected with 0.5–50 × 106 CFU M. tuberculosis. As a control stimulus, LPS was used at 10 ng/ml (22).

Pulmonary infection of experimental animals with M. tuberculosis with a natural dose of 100 CFU/lung or a high dose of 2000 CFU M. tuberculosis per lung was performed as described (14). Inoculum size was confirmed 24 h postinfection by determining the bacterial load in the lungs of infected mice.

Colony enumeration assay

At different time points after infection with M. tuberculosis, lungs of sacrificed animals were removed aseptically and weighed, and one lobe per mouse was homogenized in PBS containing a proteinase inhibitor mixture (Roche Diagnostics, Mannheim, Germany). For colony enumeration, 10-fold serial dilutions of organ homogenates were plated in duplicates and processed as described (14).

Immunohistological analysis

One lung lobe per mouse was fixed in 4% formalin-PBS, set in paraffin blocks, and sectioned (2–3 μm). For immunohistology, tissue sections were prepared and stained with a polyclonal rabbit anti-mouse inducible NO synthase (iNOS) antiserum (Biomol, Hamburg, Germany) as previously described (23).

Quantification of IL-12p40, TNF, and IFN-γ by ELISA

Supernatants were collected at 24 and 96 h postinfection, and mouse TNF- and IL-12p40-concentrations in the supernatants were measured by ELISA according to the manufacturer’s instructions (R&D Systems, Minneapolis, MN and BD Bioscience, Heidelberg, Germany, respectively). Cytokine levels (TNF, IL-12p40, IFN-γ) in lung homogenates and serum from infected mice were analyzed in 3-fold serial dilutions by a sandwich ELISA (OptEia; BD Bioscience).

Statistical analysis

Data are expressed as the means of individual determinations and SD. Statistical analysis was performed using the Student t test or the log rank survival test.

Results and Discussion

Course of aerosol infection with 100 CFU M. tuberculosis in mice deficient in CD14, TLR2, or TLR4

During the course of aerosol infection with 100 CFU M. tuberculosis, the bacterial load in the lungs of BALB/c mice was almost identical with that found in CD14−/− mice (Fig. 1⇓a). Likewise, TLR4-defective C3H/HeJ (Fig. 1⇓b) and TLR2−/− mice (Fig. 1⇓c) were as resistant to aerosol infection with M. tuberculosis as congenic control mice, respectively, refuting the hypothesis that TLR2 or TLR4 by themselves are of pivotal significance for innate resistance. In contrast, low-dose aerosol infection performed in parallel in mice deficient in iNOS or TNFRp55 (TNFR of 55 kDa), both known to be critical components of innate immunity, resulted in significantly increased pulmonary bacterial loads, in agreement with previously published data (Refs. 15 and 24 ; data not shown). All iNOS−/− and TNFRp55−/− mice died around day 50, whereas control mice and all mice deficient in PRRs were still alive even at 14 wk postinfection. In summary, the presence of CD14, TLR4, or TLR2 is dispensable for mounting adequate innate resistance to aerogenic infection with M. tuberculosis.

           FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

M. tuberculosis CFU counts in the lungs of aerosol-infected mice deficient in CD14, TLR4, or TLR2 function. Control (•) and deficient mice (○) were aerogenically infected with 100 CFU M. tuberculosis. CFU counts were determined at indicated time points. Lungs were taken from BALB/c and CD14−/− (a), C3H/HeN and TLR4-defective C3H/HeJ (b), and C57BL/6 and TLR2−/− (c) mice. Data represent means ± SD of four mice. One experiment representative of three performed is shown.

Analysis of immune responses in the lungs of M. tuberculosis-infected mice defective in CD14, TLR2, or TLR4

Because containment of bacterial replication is only one facet of an effective immune response, we analyzed whether other parameters indicative of inflammatory and protective processes might be altered in defective mice. IL-12p40, TNF, and IFN-γ were produced at comparably high levels independently of CD14-, TLR2-, or TLR4-mediated signaling in the lungs of M. tuberculosis-infected mice (Table I⇓). There were significant differences in the absolute amount of cytokines detected in lung homogenates between the three groups of mice examined, likely reflecting the difference in their genetic backgrounds.

View this table:
  • View inline
  • View popup
Table I.

Cytokine production in lung homogenates from CD14-, TLR2-, and TLR4-defective mice after infection with M. tuberculosis

It was reported that M. tuberculosis-derived TLR2 agonists inhibit Ag processing and MHC class II expression in macrophages. However, flow cytometric analysis of bronchioalveolar macrophages at day 21 postinfection showed no significant difference in the expression levels of MHC class II in M. tuberculosis-infected TLR2-deficient vs congenic control mice (data not shown). This was paralleled by comparably increased numbers of CD4+, CD8+, and activated CD4+ cells in mediastinal lymph nodes (data not shown) as well as efficient epithelioid granuloma formation in all groups of mice (Fig. 2⇓ and data not shown). In addition, iNOS expression, a marker of macrophage activation, was similar in granulomatous lesions in lungs from mice defective in CD14, TLR2, or TLR4 and congenic control mice (Fig. 2⇓ and data not shown).

           FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Granuloma formation in the lungs of M. tuberculosis-infected TLR2−/− mice. Sections (2–3 μm) were prepared from formalin-fixed lungs taken from TLR2−/− and C57BL/6 mice 49 days after aerosol infection with 100 CFU M. tuberculosis. Immunohistological staining was performed with a polyclonal rabbit anti-mouse iNOS antiserum. Shown are representative results of four mice per group obtained in three independent experiments. Arrows indicate lymphocyte aggregates; brown staining shows iNOS-positive epithelioid macrophages. Bar, 0.5 mm.

Recently, signaling via TLRs was implicated in generating adaptive immune responses (25). Our data obtained in low-dose aerosol infection with M. tuberculosis argue that development of adaptive immunity, as revealed by the generation of effector T cells and the prolonged containment of bacterial loads in compact granulomas, can also effectively proceed in a CD14-, TLR2-, or TLR4-independent fashion. A limitation of our study is that the observation period does not cover the entire life span of infected mice. Therefore, mechanisms active predominantly in controlling chronically persistent infection, e.g., release of perforin (26), may still be regulated by TLRs. Also, recent findings point to combinatorial actions of TLRs (27). It is therefore possible that the lack of more than one TLR would impair innate immunity to M. tuberculosis infection. Experiments in TLR2/TLR4 double-deficient mice and in mice lacking the TLR adaptor molecule MyD88 (28) are required to resolve this issue.

M. tuberculosis infection of bone-marrow derived macrophages from mice deficient in CD14, TLR2, or TLR4

The results from our aerosol infection in mutant mice is in striking contrast to the hypothesized critical role for PRRs in innate immune responses. However, current thinking is primarily based on results obtained from in vitro stimulation experiments performed on cell lines transfected with, e.g., CD14, TLR2, or TLR4 (11, 29). To date, few data are available from primary macrophages addressing the roles of PRRs for initiating cytokine secretion in response to M. tuberculosis.

We found TNF and IL-12p40 production after infection of murine primary macrophages with live M. tuberculosis to be independent of CD14 (Fig. 3⇓a, 3 day). In contrast, in TLR2−/− macrophages, TNF and IL-12p40 production were drastically reduced after stimulation with M. tuberculosis (Fig. 3⇓, b and e). Although TNF production was not significantly decreased, IL-12p40 levels were ∼65% lower in TLR4-defective C3H/HeJ macrophages when compared with simultaneously infected C3H/HeN macrophages (Fig. 3⇓, c and f). Taken together, our in vitro infection experiments with primary macrophages corroborate earlier reports in transfected cells (11, 29) and show that engagement of TLR2 and TLR4 on macrophages indeed contributes to proinflammatory cytokine secretion in response to M. tuberculosis, whereas CD14 is not involved.

           FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

M. tuberculosis-induced TNF and IL-12p40 secretion in bone marrow-derived macrophages from CD14- or TLR2-deficient or TLR4-defective mice. Bone marrow-derived macrophages from CD14−/− (a and d), TLR2−/− (b and e), and TLR4-defective C3H/HeJ (c and f) as well as control mice were incubated with indicated multiplicities of infection (MOI) of viable M. tuberculosis. Supernatants were harvested 24 or 96 h after infection and measured for TNF and IL-12p40 concentrations, respectively. Data from one representative experiment of three are shown. Each point indicates the means + SD (error bars) of triplicate values. ∗, p < 0.05; ∗∗, p < 0.005; ∗∗∗, p < 0.005; n.s., not significant.

High-dose aerosol infection with M. tuberculosis in TLR4-defective and TLR2-deficient mice

If TLR2- and TLR4-mediated signals significantly contribute to proinflammatory cytokine secretion in vitro, how is it possible that defective signaling in either of these molecules does not result in a discernible lack of resistance during aerosol infection in vivo? In gene-deficient mice, a distinct phenotype may often only become apparent if the missing molecule plays a nonredundant role. Additional insight may be gained from examining an experimental situation in which compensatory processes are minimized and in which even molecules that are not essential during a natural exposure need to be recruited to control the insult. In support of this reasoning, increased susceptibility of TLR2−/− mice to i.v. Staphylococcus aureus infection was only apparent when a very high inoculum dose of 1 × 107 CFU, representing an LD50 for wildtype mice, was used (30).

To mimick a similar situation in the M. tuberculosis model, mice were infected with an inoculum of 2000 CFU by aerosol. TLR4-defective C3H/HeJ mice still proved to be as resistant to high-dose infection with M. tuberculosis as C3H/HeN mice (Fig. 4⇓a), confirming previous results from a high-dose i.v. infection model (31). Both groups of mice produced similar amounts of IL-12p40 following high-dose infection, providing a likely explanation for the similar outcome in these mice (Fig. 4⇓a). In striking contrast, TLR2−/− mice were significantly more susceptible to high-dose aerosol M. tuberculosis infection than control mice (Fig. 4⇓b). This enhanced susceptibility could be attributed to a significantly decreased proinflammatory response of TLR2−/− mice as evidenced by reduced serum levels of IL-12p40 10 days postinfection (Fig. 4⇓b). These data clearly implicate TLR2, but not TLR4, in initiating antibacterial resistance in a borderline situation presented by a high inoculum.

           FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

High-dose aerosol infection of TLR4-defective or TLR2-deficient mice with M. tuberculosis. Control (•) and deficient mice (○) were aerogenically infected with 2000 CFU M. tuberculosis. C3H/HeN and C3H/HeJ mice (a; 6 mice per group) or TLR2−/− and C57BL/6 mice (b; 10 mice per group) were monitored for survival. Moribund mice were sacrificed. Survival rates of C57BL/6 and TLR2−/− mice were significantly different (p < 0.05). After 10 days, a separate identically infected group of mice was sacrificed to determine IL-12p40 production in serum. ELISA data represent means ± SD of 4 mice per group. Differences in IL-12p40 production between C57BL/6 and TLR2−/− mice were statistically significant (∗, p < 0.05; n.s., not significant).

Collectively, our findings may be interpreted as follows: during natural, i.e., aerogenic and low-dose infection, M. tuberculosis triggers little, if any, response via CD14, TLR4, or TLR2. This may reflect the preferred mode of “surreptitious entry” for this highly pathogenic organism, causing as little inflammation as possible to establish infection in the lung and regional lymph nodes. Our results thus support the notion that a single deficiency in PRRs capable of detecting mycobacteria or mycobacterial components (such as CD14, TLR4, or TLR2) does not impair innate resistance to natural M. tuberculosis infection.

Acknowledgments

We thank Johanna Suwinski for expert technical assistance with in vivo infections and Sven Mohr for taking care of the mice.

Footnotes

  • ↵1 This work was supported in part by a research grant from the Deutsche Forschungsgemeinschaft (SFB 415, C7).

  • ↵2 N.R. and C.H. contributed equally to this work.

  • ↵3 Address correspondence and reprint requests to Dr. Stefan Ehlers, Division of Molecular Infection Biology, Research Center Borstel, Parkallee 22, D-23845 Borstel, Germany. E-mail address: sehlers{at}fz-borstel.de

  • ↵4 Abbreviations used in this paper: PRR, pattern recognition receptor, TLR, Toll-like receptor; iNOS, inducible NO synthase.

  • Received July 8, 2002.
  • Accepted August 9, 2002.
  • Copyright © 2002 by The American Association of Immunologists

References

  1. ↵
    World Health Organization. 2002. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report. Geneva, Switzerland, WHO/CDS/TB/2002.295.
  2. ↵
    North, R. J.. 1995. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J. Infect. Dis. 172: 1550
    OpenUrlAbstract/FREE Full Text
  3. ↵
    McMurray, D. N., F. M. Collins, A. M. Dannenberg, Jr, D. W. Smith. 1996. Pathogenesis of experimental tuberculosis in animal models. Curr. Top. Microbiol. Immunol. 215: 157
    OpenUrlPubMed
  4. ↵
    Saunders, B. M., A. M. Cooper. 2000. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol. Cell Biol. 78: 334
    OpenUrlCrossRefPubMed
  5. ↵
    Flynn, J. L., J. D. Ernst. 2000. Immune responses in tuberculosis. Curr. Opin. Immunol. 12: 432
    OpenUrlCrossRefPubMed
  6. ↵
    Kaufmann, S. H.. 2001. How can immunology contribute to the control of tuberculosis?. Nature Rev. Immunol. 1: 20
    OpenUrlCrossRefPubMed
  7. ↵
    Trinchieri, G.. 1993. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today 14: 335
    OpenUrlCrossRefPubMed
  8. ↵
    Akira, S., K. Takeda, T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675
    OpenUrlCrossRefPubMed
  9. ↵
    Aderem, A., R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782
    OpenUrlCrossRefPubMed
  10. ↵
    Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components. J. Clin. Invest 91: 2076
    OpenUrlCrossRefPubMed
  11. ↵
    Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, M. J. Fenton. 1999. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163: 3920
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Thoma-Uszynski, S., S. Stenger, O. Takeuchi, M. T. Ochoa, M. Engele, P. A. Sieling, P. F. Barnes, M. Rollinghoff, P. L. Bolcskei, M. Wagner, et al 2001. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 291: 1544
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285: 732
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Holscher, C., R. A. Atkinson, B. Arendse, N. Brown, E. Myburgh, G. Alber, F. Brombacher. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167: 6957
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2: 561
    OpenUrlCrossRefPubMed
  16. ↵
    van Crevel, R., T. H. Ottenhoff, J. W. Der Meer. 2002. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15: 294
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Stenger, S., R. L. Modlin. 2002. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr. Opin. Immunol. 14: 452
    OpenUrlCrossRefPubMed
  18. ↵
    Heldwein, K. A., M. J. Fenton. 2002. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 4: 937
    OpenUrlCrossRefPubMed
  19. ↵
    Werts, C., R. I. Tapping, J. C. Mathison, T. H. Chuang, V. Kravchenko, G. Saint, I. D. A. Haake, P. J. Godowski, F. Hayashi, A. Ozinsky, et al 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2: 346
    OpenUrlCrossRefPubMed
  20. ↵
    Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity. 4: 407
    OpenUrlCrossRefPubMed
  21. ↵
    Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Reiling, N., K. Klug, U. Krallmann-Wenzel, R. Laves, S. M. Goyert, M. E. Taylor, T. K. Lindhorst, S. Ehlers. 2001. Complex encounters at the macrophage-mycobacterium interface: studies on the role of the mannose receptor and CD14 in experimental infection models with Mycobacterium avium. Immunobiology 204: 558
    OpenUrlCrossRefPubMed
  23. ↵
    Cooper, A. M., J. E. Pearl, J. V. Brooks, S. Ehlers, I. M. Orme. 2000. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68: 6879
    OpenUrlAbstract/FREE Full Text
  24. ↵
    MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94: 5243
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2: 947
    OpenUrlCrossRefPubMed
  26. ↵
    Sousa, A. O., R. J. Mazzaccaro, R. G. Russell, F. K. Lee, O. C. Turner, S. Hong, L. Van Kaer, B. R. Bloom. 2000. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 97: 4204
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Hajjar, A. M., D. S. O’Mahony, A. Ozinsky, D. M. Underhill, A. Aderem, S. J. Klebanoff, C. B. Wilson. 2001. Cutting edge: functional interactions between Toll-like receptor (TLR)2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166: 15
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Takeuchi, O., K. Takeda, K. Hoshino, O. Adachi, T. Ogawa, S. Akira. 2000. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 12: 113
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Means, T. K., B. W. Jones, A. B. Schromm, B. A. Shurtleff, J. A. Smith, J. Keane, D. T. Golenbock, S. N. Vogel, M. J. Fenton. 2001. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J. Immunol. 166: 4074
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Takeuchi, O., K. Hoshino, S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165: 5392
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Chackerian, A. A., T. V. Perera, S. M. Behar. 2001. γ interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 69: 2666
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 169 (7)
The Journal of Immunology
Vol. 169, Issue 7
1 Oct 2002
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis
Norbert Reiling, Christoph Hölscher, Alexandra Fehrenbach, Svenja Kröger, Carsten J. Kirschning, Sanna Goyert, Stefan Ehlers
The Journal of Immunology October 1, 2002, 169 (7) 3480-3484; DOI: 10.4049/jimmunol.169.7.3480

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis
Norbert Reiling, Christoph Hölscher, Alexandra Fehrenbach, Svenja Kröger, Carsten J. Kirschning, Sanna Goyert, Stefan Ehlers
The Journal of Immunology October 1, 2002, 169 (7) 3480-3484; DOI: 10.4049/jimmunol.169.7.3480
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
  • Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil
  • Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606